Genomics and omics
Cancer genomics
8 papers and 17 abstracts co-authored by Raphael E. Szalat. Current lab members are shown in bold.
Papers 8
- 2026
Genomically Smoldering Multiple Myeloma Is Not a Distinct Entity But a Collection of Monoclonal Gammopathy of Undetermined Significance or Multiple Myeloma
- 2021
Genetic Predictors of Mortality in Patients with Multiple Myeloma
- 2020
Genome-Wide Somatic Alterations in Multiple Myeloma Reveal a Superior Outcome Group
- 2019
Genomic landscape and chronological reconstruction of driver events in multiple myeloma
- 2018
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
- 2018
Genomic patterns of progression in smoldering multiple myeloma
- 2018
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
- 2016
Next-Generation Sequencing Informing Therapeutic Decisions and Personalized Approaches
Abstracts & posters 17
- 2020
High Throughput Genomic Analysis Identifies Low-Risk Smoldering Multiple Myeloma
- 2019
E2 ubiquitin conjugase UBE2T contributes to genome maintenance through homologous recombination in multiple myeloma
- 2019
Genome wide chromatin accessibility profiling identifies chromatin signatures and novel transcription factor dependencies in multiple myeloma
- 2019
Lack of Significant Differences in Somatic Alterations between MGUS, SMM and Symptomatic Multiple Myeloma: A Result from Comprehensive Genomic Profiling Study
- 2019
Recurrent somatic Alterations in the Non-Coding Genome Alter Gene Expression Levels and Correlate With Clinical Outcome
- 2019
S119 THE ROLE OF RECURRENT SOMATIC ALTERATIONS IN THE NON-CODING GENOME WITH FUNCTIONAL IMPLICATIONS IN MM
- 2019
The Landscape of Genome Wide Somatic Alterations Identifies a Good-Risk Group in Newly Diagnosed Multiple Myeloma
- 2018
Analysis of mutations and structural variants to redefine the genomic landscape of multiple myeloma and its clinical implications
- 2018
Landscape of Recurrent Mutations in Non-Coding Genome with Functional Implications in Newly-Diagnosed Multiple Myeloma
- 2018
The genomic landscape of structural variations and complex events in multiple myeloma
- 2017
Integrative Oncogenomic Analysis Combining Whole Genome, Transcriptome and Epigenome Identifies Altered Chromatin Accessibility Landscape in Multiple Myeloma
- 2017
The genomic landscape of multiple myeloma complex structural variations
- 2016
A targeted sequencing approach in multiple myeloma reveals a complex landscape of genomic lesions that has implications for prognosis
- 2016
Analysis of Mutational Signatures Suggest That Aid Has an Early and Driver Role in Multiple Myeloma
- 2016
Global Genomic Analysis of Newly Diagnosed t(4 ;14) Multiple Myeloma Reveals a Specific Mutational Spectrum and Identifies PKD2 As a Potential Therapeutic Target
- 2016
The Complex Landscape of Rearrangements in Smoldering and Symptomatic Multiple Myeloma Revealed By Whole-Genome Sequencing
- 2016
Whole Genome Sequencing of Unique Paired SMM/MGUS Progressing to MM Samples Reveals a Genomic Landscape with Diverse Evolutionary Pattern